Medicaid Leaders Comment on 21st Century Cures

In a letter to the House Energy and Commerce Committee, the National Association of Medicaid Directors urged members to focus on the potential risks of new drugs and devices for patients as they continue work on the 21st Century Cures Initiative. “Federal policymakers must assess the impact to U.S. prescription drug budgets, insurance premiums and costs borne by the state Medicaid programs, taxpayers and patients,” the letter says. “New pathways and incentives should include appropriate protections for vulnerable patients, particularly those enrolled in the Medicaid program, to ensure they are not inadvertently subject to adverse consequences.” The 21st Century Cures Initiative is aimed at making the approval of new health products faster and more efficient.

Upcoming Congressional Meetings and Hearings

Senate Caucus on International Narcotics Control: hearing on the quota system used to manage controlled substances; time and place TBD

Senate Finance Committee: hearing titled “Creating a More Efficient and Level Playing Field: Audit and Appeals Issues in Medicare;” time and place TBD

House Veterans’ Affairs Oversight and Investigations Subcommittee: markup of HR 1016, the “Biological Implant Tracking and Veteran Safety Act of 2015;” 4:00 p.m., 334 Cannon Bldg.; April 21

Senate Finance Health Care Subcommittee: hearing titled “A Fresh Look at the Impact of the Medical Device Tax on Jobs, Innovation and Patients;” 10:00 a.m., 215 Dirksen Bldg.; April 23

Senate Appropriations Labor, Health and Human Services, Education and Related Agencies Subcommittee: hearing on proposed fiscal 2016 appropriations for programs under its jurisdiction – Department of Health and Human Services; 10:00 a.m., 124 Dirksen Bldg.; April 23

House Veterans’ Affairs Health Subcommittee: hearing on veterans health and safety legislation; 10:00 a.m., 334 Cannon Bldg.; April 23

House Energy and Commerce Oversight and Investigations Subcommittee: hearing titled “Combatting the Opioid Abuse Epidemic: Professional and Academic Perspectives;” 10:15 a.m., 2322 Rayburn Bldg.; April 23

Senate Health, Education, Labor and Pensions Committee: hearing titled “Continuing America’s Leadership: The Future of Medical Innovation for Patients;” 10:00 a.m., 430 Dirksen Bldg., April 28

House Veterans’ Affairs Committee: hearing titled “Examining Access and Quality of Care and Services for Women Veterans;” 10:30 a.m., 334 Cannon Bldg.; April 30

House Veterans’ Affairs Committee: hearing titled “Assessing the Promise and Progress of the Choice Program;” 10:30 a.m., 334 Cannon Bldg.; May 13

December 31, 1969: | Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7



 -  2019

 +  2018